secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vivani Medical, Inc. (VANI)
CIK:        0001266806
Form:       8-K
Filed at:   2025-03-27T23:59:59+00:00
Accession:  0001753926-25-000495
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vivani Medical raises $8.25M in private placement led by Chairman; extends cash runway into Q2 2026
--------------------------------------------------------------------------------

- Issued 7,366,071 shares at $1.12 each to an entity beneficially owned by Chairman Gregg Williams.
- Gross proceeds of ~$8.25M; no warrants, discounts, or placement agent fees incurred.
- Funding expected to extend cash runway into Q2 2026 and accelerate NPM-139 (semaglutide) implant development.
- Placement occurs over multiple closings through January 15, 2026, under Rule 506/Regulation D.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1266806/000175392625000495/0001753926-25-000495-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1266806/000175392625000495/vani-20250326.htm
  HTML page:      https://secwatch.observer/filing/0001753926-25-000495

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer